Rivaroxaban and other novel anticoagulants for stroke prevention in atrial fibrillation: time to embrace the future

被引：0
作者：
Rajappan, Kim [1 ]
机构：
[1] John Radcliffe Hosp, Dept Cardiac, Oxford OX3 9DU, England
来源：
HEART | 2013年 / 99卷 / 06期
关键词：
RISK; WARFARIN;
D O I：
10.1136/heartjnl-2012-302762
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：361 / 362
页数：2
相关论文
共 14 条
  • [1] [Anonymous], NICE TECHN APPR GUID
  • [2] Why do patients with atrial fibrillation not receive warfarin?
    Bungard, TJ
    Ghali, WA
    Teo, KK
    McAlister, FA
    Tsuyuki, RT
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (01) : 41 - 46
  • [3] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151
  • [4] Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
    Go, AS
    Hylek, EM
    Borowsky, LH
    Phillips, KA
    Selby, JV
    Singer, DE
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 131 (12) : 927 - +
  • [5] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) : 981 - 992
  • [6] Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
    Hart, RG
    Benavente, O
    McBride, R
    Pearce, LA
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 131 (07) : 492 - +
  • [7] Subclinical Atrial Fibrillation and the Risk of Stroke
    Healey, Jeff S.
    Connolly, Stuart J.
    Gold, Michael R.
    Israel, Carsten W.
    Van Gelder, Isabelle C.
    Capucci, Alessandro
    Lau, C. P.
    Fain, Eric
    Yang, Sean
    Bailleul, Christophe
    Morillo, Carlos A.
    Carlson, Mark
    Themeles, Ellison
    Kaufman, Elizabeth S.
    Hohnloser, Stefan H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) : 120 - 129
  • [8] Atrial fibrillation - the growing epidemic
    Lip, Gregory Y. H.
    Kakar, Puneet
    Watson, Timothy
    [J]. HEART, 2007, 93 (05) : 542 - 543
  • [9] Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
    Lip, Gregory Y. H.
    Nieuwlaat, Robby
    Pisters, Ron
    Lane, Deirdre A.
    Crijns, Harry J. G. M.
    [J]. CHEST, 2010, 137 (02) : 263 - 272
  • [10] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
    Patel, Manesh R.
    Mahaffey, Kenneth W.
    Garg, Jyotsna
    Pan, Guohua
    Singer, Daniel E.
    Hacke, Werner
    Breithardt, Guenter
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Piccini, Jonathan P.
    Becker, Richard C.
    Nessel, Christopher C.
    Paolini, John F.
    Berkowitz, Scott D.
    Fox, Keith A. A.
    Califf, Robert M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (10) : 883 - 891
12